Massivemarkets

ZBH

Zimmer Biomet Holdings, Inc.

NYSE · usd

$98.56-0.25 (-0.25%)
As of 4:20:00 PM EDT on Oct 23, 2026 · 15-minute delayed

Zimmer Biomet Holdings, Inc. (ZBH) trades at $98.56 (-0.25%) as of 4:20:00 PM EDT on Oct 23, 2026, +9.89% over the past month. Market cap is $18.85B, with 4.4 days to cover in short interest.

Stock performance

How Zimmer Biomet Holdings, Inc. (ZBH) stock has performed from one day to one year, with its 52-week range.

-0.32%
-$0.31 over 1D
$97.75$98.15$98.56$98.979:30 AM11:10 AM12:45 PM2:25 PM4:00 PM$98.56
1D
-0.25%
1W
+3.77%
1M
+9.89%
YTD
+9.61%
1Y
-4.34%
52-wk range
$79.12 – $104.15

Key statistics

Today's trading snapshot for ZBH: day range, open, previous close, volume and market cap.

Day range
$97.42 – $99.32
Open
$98.37
Prev close
$98.81
Volume
2.02M
Market cap
$18.85B
Shares out
190.74M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for Zimmer Biomet Holdings, Inc.: P/E, P/S, P/B, ROE and more.

P/E
23.36
P/S
2.21
P/B
1.49
P/FCF
17.78
ROE
6.4%
ROA
3.5%
Debt/Equity
0.59
Div yield
1.00%

As of Oct 22, 2026

8-K filings

Material corporate events Zimmer Biomet Holdings, Inc. has disclosed to the SEC on Form 8-K.

  • Executive leadershipSep 8, 2026

    On September 8, 2026, Zimmer Biomet Holdings, Inc. notified Kevin Thornal, Group President, Global Businesses and the Americas, that his position is being restructured. Mr. Thornal will be departing from the Company, effective on September 30, 2026.

  • Debt activityJun 29, 2026

    The 364-Day Revolving Credit Agreement, dated as of June 26, 2026, among the Company, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent (the "364-Day Credit Agreement"), is an unsecured revolving credit facility in the principal amount of $1.25 billion (the "364-Day Revolving Facility"). The 364-Day Credit Agreement will mature on June 25, 2027.

  • Shareholder meetingsMay 27, 2026

    Zimmer Biomet Holdings, Inc. (the "Company") held its annual meeting of shareholders on May 22, 2026. Shareholders took the following actions: elected ten (10) directors for one-year terms ending at the 2027 annual meeting of shareholders (Proposal 1); ratified the Audit Committee's appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2026 (Proposal 2); approved, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's proxy statement (Proposal 3); and rejected a shareholder proposal on Independent Board Chairman (Proposal 4).

  • Shareholder returnsMay 12, 2026

    Zimmer Biomet Holdings, Inc. stated its intent to repurchase up to $1.0 billion of Company shares during fiscal year 2026 under the Company's existing $1.5 billion share repurchase authorization, which had previously been approved by the Board of Directors of the Company in February 2026. This represents an increase from the Company's previously-disclosed capital allocation assumptions for fiscal year 2026.

  • Executive leadershipApr 28, 2026

    On April 22, 2026, Suketu Upadhyay informed Zimmer Biomet Holdings, Inc. (the "Company") of his intention to resign from the position of Chief Financial Officer and Executive Vice President – Finance, Operations and Supply Chain of the Company, effective as of April 28, 2026, to pursue a new professional opportunity.

Dividend history and stock splits

Zimmer Biomet Holdings, Inc.'s recent dividend payments and stock splits.

Dividends

  • $0.24ex-div Sep 30, 2026
  • $0.24ex-div Jun 25, 2026
  • $0.24ex-div Mar 31, 2026
  • $0.24ex-div Dec 30, 2025

Splits

No recent splits.

ZBH short interest

How heavily ZBH is shorted: shares short, days to cover and average daily volume.

Days to cover
4.4
Short interest
9.75M
Avg volume
2.22M

As of · reported to FINRA twice monthly.

ZBH news

The latest news and headlines about Zimmer Biomet Holdings, Inc. (ZBH).

Frequently asked questions

What is the Zimmer Biomet Holdings, Inc. (ZBH) stock price today?

Zimmer Biomet Holdings, Inc. (ZBH) is trading at $98.56 (-0.25% on the day) as of 4:20:00 PM EDT on Oct 23, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is Zimmer Biomet Holdings, Inc.?

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in…

What is the short interest in ZBH?

As of Sep 30, 2026, ZBH has 9.75M shares short and 4.4 days to cover.

Does Zimmer Biomet Holdings, Inc. (ZBH) pay a dividend?

Yes. Zimmer Biomet Holdings, Inc. (ZBH)'s most recent dividend was $0.24 per share, with an ex-dividend date of Sep 30, 2026. Full ZBH dividend history is available from the Massive API.

What exchange is ZBH listed on?

Zimmer Biomet Holdings, Inc. (ZBH) trades on NYSE in USD, in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES industry.

Build with AI

Build an analysis of ZBH with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a ZBH analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Want the most up-to-date, real-time data? Connect to the Massive API and MCP server — the source behind every number on this page — covering stocks, options, indices, currencies and futures. Docs: https://massive.com/docs/rest. Get a free API key.

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.